Parkwood LLC Ngm Biopharmaceuticals Inc Transaction History

Parkwood LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.41 - $12.93 $81,840 - $310,320	24,000 Added 54.16%	68,314 $343,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $557,913 - $783,028	44,314 New	44,314 $580,000
Q4 2021 Feb 11, 2022	SELL	$17.26 - $22.02 $863,000 - $1.1 Million	-50,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$20.15 - $26.19 $1.01 Million - $1.31 Million	50,000 New	50,000 $1.05 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.